ClinicalTrials.gov
ClinicalTrials.gov Menu

a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China (SMS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01837121
Recruitment Status : Completed
First Posted : April 22, 2013
Last Update Posted : January 9, 2018
Sponsor:
Collaborators:
Orbis
The World Diabetes Foundation
Information provided by (Responsible Party):
Congdon Nathan, Sun Yat-sen University

Brief Summary:
The purpose of this study is to use a randomized controlled design to determine the impact of a SMS messaging intervention on the following outcomes among persons diagnosed with diabetic retinopathy in rural China.

Condition or disease Intervention/treatment Phase
Compliance Diabetic Retinopathy SMS Other: the SMS reminder message Not Applicable

Detailed Description:
SMS message reminder is a system which can sent re-visit information to remind the patient about the revisit time and address. The investigators can use the SMS system to find out if it is a useful to reduce the not-attended rate of the revisit appointment among the rural diabetic retinopathy patients.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 237 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Care Provider, Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: a Randomized Controlled Trail to Determine the Impact of a SMS Reminder Among Diabetic Retinopathy Patients in Rural China
Actual Study Start Date : January 2015
Actual Primary Completion Date : June 2017
Actual Study Completion Date : June 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
the SMS group
the diabetic retinopathy patient in the SMS group will receive a SMS reminder message about the revisit time,address 1 week and 3 day before the appointment.
Other: the SMS reminder message
the SMS reminder message will sent to the SMS group patients 1 week and 3 day before there appointment,to remind them the exact time and address of the revisit appointment.

No Intervention: the control group
the diabetic retinopathy patient in the control group won't get any reminder message before the appointment.



Primary Outcome Measures :
  1. Not-attended rate [ Time Frame: up to 1.5 years ]
    Compare the SMS patient not-attended rate with the control group to show the impact of SMS reminder on the compliance with scheduled follow-up visit


Secondary Outcome Measures :
  1. Knowledge about Diabetic retinopathy on a standardized examination [ Time Frame: up to 1.5 years ]
    Using a questionnaire about the comprehensive eye exam and Diabetic retinopathy to compare Knowledge about Diabetic retinopathy on a standardized examination between the SMS group and the control group

  2. Presenting vision [ Time Frame: up to 1.5 years ]
    Presenting vision(Best corrected visual acuity) in the better-seeing and worse-seeing eyes of the two group

  3. Loss of presenting vision [ Time Frame: up to 1.5 years ]
    Loss of presenting vision(Best corrected visual acuity) in better-seeing eye thought due to Diabetic retinopathy

  4. Satisfaction with care [ Time Frame: up tp 1.5 years ]
    Using a patient satisfaction questionnaire to compare satisfaction with care between the SMS group and the control group



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

- all the diabetes patients who would like to join our study in 5 CREST cooperated rural hospitals.

Exclusion Criteria:

  1. Both the patient and his/her caretakers don't have cellphone,or the one who has cellphone but don't know how to use the SMS function.
  2. The first re-visit appointment time is outside our study period.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01837121


Locations
China, Guangdong
Blindness Preventment and Treatment Department, Zhongshan Ophthalmic Center
Guangzhou, Guangdong, China, 510060
Sponsors and Collaborators
Sun Yat-sen University
Orbis
The World Diabetes Foundation
Investigators
Study Director: Nathan G Congdon, MD,MPH Blindness Prevention and Treament Department,Zhongshan Ophthalmic Center

Responsible Party: Congdon Nathan, vice director,Blindness Prevention and Treatment Department, Sun Yat-sen University
ClinicalTrials.gov Identifier: NCT01837121     History of Changes
Other Study ID Numbers: ZOC-WDF-SMS
First Posted: April 22, 2013    Key Record Dates
Last Update Posted: January 9, 2018
Last Verified: January 2018

Keywords provided by Congdon Nathan, Sun Yat-sen University:
not-attended rate
re-visit
vision
knowledge
satisfaction

Additional relevant MeSH terms:
Retinal Diseases
Diabetic Retinopathy
Eye Diseases
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases